Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06573645
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-02
Brief Title:
A Phase III Clinical Trial of High-dose Rituximab 500mgm² Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL
Sponsor:
None
Organization:
None
Organization Data
Organization:
None
Class:
None
Study ID:
None
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
None
Lead Sponsor Class:
None
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None